Vitrolife (Q2 initial take): Soft top-line but strong and improving profitability - Redeye

Vitrolife's Q2 report came in mixed showing -1% organic sales growth which was offset by an elevated EBITDA profitability of 34% in the quarter, with the restructuring efforts starting to bear fruit.

Länk till analysen i sin helhet: https://www.redeye.se/research/1174775/vitrolife-q2-initial-take-soft-top-line-but-strong-and-improving-profitability?utm_source=finwire&utm_medium=RSS